JPMORGAN CHASE & CO - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for Radiopharm Theranostics Limited

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares
Shares outstanding: 2.26B shares
Disclosed Ownership: 231M shares
Ownership: 10.2%
Form type: SCHEDULE 13G
Date filed: 2/11/2025, 12:16 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	10.2%	231M	231M	0	Rachel Tsvaygoft	Vice President